Vor Biopharma Inc. (VOR)

NMS – Real vaqt narxi. Valyuta: USD

22.68

-0.91 (-3.86%)

Bozor ochiq: Aug 12, 2026, 3:09 PM EDT

23.73

+0.14 (0.61%)

Oldingi bozordan keyin: Aug 11, 2026, 7:36 PM EDT

03.08.2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on August 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 32,550 shares of Vor Bio's common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 6,900 shares of Vor Bio's common stock to 5 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).

Videolar

No Data

There is no data to display

Press-relizlar

03.08.2026

Vor Biopharma Inc. (VOR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Vor Biopharma Inc. (VOR)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Search stocks

Vor Biopharma Inc. (VOR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Vor Biopharma Inc. (VOR)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)